Achieving Viral Suppression in 90% of People Living With Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities

Author:

Nachega Jean B12345,Sam-Agudu Nadia A678,Mofenson Lynne M9,Schechter Mauro10,Mellors John W11

Affiliation:

1. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania

2. Department of Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, Pennsylvania

3. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

4. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

5. Department of Medicine and Centre for Infectious Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa

6. Institute of Human Virology, University of Maryland School of Medicine, Baltimore

7. International Research Center of Excellence, Institute of Human Virology Nigeria, Abuja

8. Department of Paediatrics, University of Cape Coast School of Medical Sciences, Ghana

9. Elizabeth Glaser Pediatric AIDS Foundation, Washington, D.C.

10. Projeto Praça Onze, Universidade Federal do Rio de Janeiro, Brazil

11. Division of Infectious Diseases, University of Pittsburgh, School of Medicine, Pennsylvania

Abstract

Abstract Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third “90%” (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and ‑supported, cost-effective, and tailored to a wide range of global communities.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3